GlassScriptPhysician profile
Tamara K Haas
NPI 1801963509
$729.07
in general payments reported to CMS, 2019-2025
7 companies · $267 in 2025
The $267 reported for 2025 was more than what 92% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.23 · 2022: $18.90 · 2023: $238 · 2024: $185 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465 · Travel and Lodging: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $465.42 |
| Travel and Lodging | $224.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $360.99 | 2023-2024 | Nalu Neurostimulation System |
| Regeneron Pharmaceuticals, INC. | $224.52 | 2025 | |
| Nestle Healthcare Nutrition INC. | $39.13 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.54 | 2023 | Entyvio |
| Janssen Biotech, INC. | $28.37 | 2023 | Stelara |
| Boston Scientific Corporation | $25.39 | 2025 | General - Pain Management |
| Pfizer INC. | $17.13 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.